NCT00062712View on ClinicalTrials.gov

Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 9, 2003

Study Completion Date

March 22, 2007

Conditions

Kidney Transplantation

Interventions

DRUG

Allogeneic Bone Marrow, Anti-Thymocyte Globulin (Sangstat) & Sirolimus (Wyeth-Ay

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00062712 - Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients | Biotech Hunter | Biotech Hunter